Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cypher Sales In Japan Help Cordis Achieve 19% Revenue Jump In 2004

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson's Cordis unit grew its top line 19% to $3.21 bil. in 2004, due in part to robust Cypher sirolimus-eluting stent sales in Japan, CEO William Weldon stated in a Jan. 25 earnings call

You may also be interested in...



Taxus Will Continue To Lead Coronary Stent Market, Boston Scientific Vows

Boston Scientific aspires to retain the number-one position in the coronary stent space over the next few years by consistently bringing next-generation products to market ahead of competitors

Taxus Will Continue To Lead Coronary Stent Market, Boston Scientific Vows

Boston Scientific aspires to retain the number-one position in the coronary stent space over the next few years by consistently bringing next-generation products to market ahead of competitors

Cordis Recalls 300 Underweight Cypher Units, Predicts Zero Adverse Events

Johnson & Johnson/Cordis' 300-unit recall of its Cypher sirolimus-eluting stent from 145 centers nationwide marks the most recent manufacturing glitch for the high-profile sector

Related Content

UsernamePublicRestriction

Register

MT021516

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel